These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8122887)

  • 1. Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia.
    Takahashi H; Levine RA; Galloway MP; Snow BJ; Calne DB; Nygaard TG
    Ann Neurol; 1994 Mar; 35(3):354-6. PubMed ID: 8122887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
    Hanakawa T; Fukuyama H; Akiguchi I; Kato M; Kimura J; Shibasaki H
    Rinsho Shinkeigaku; 1996 May; 36(5):655-60. PubMed ID: 8905984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopa-responsive dystonia simulating cerebral palsy.
    Nygaard TG; Waran SP; Levine RA; Naini AB; Chutorian AM
    Pediatr Neurol; 1994 Oct; 11(3):236-40. PubMed ID: 7880338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.
    Nygaard TG; Takahashi H; Heiman GA; Snow BJ; Fahn S; Calne DB
    Ann Neurol; 1992 Nov; 32(5):603-8. PubMed ID: 1449240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
    Snow BJ; Nygaard TG; Takahashi H; Calne DB
    Ann Neurol; 1993 Nov; 34(5):733-8. PubMed ID: 8239569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopamine deficiency.
    Jeon BS; Jeong JM; Park SS; Lee MC
    Adv Neurol; 1998; 78():309-17. PubMed ID: 9750927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of CSF biopterin and neopterin in hereditary progressive dystonia with marked diurnal fluctuation (HPD)--a clue to pathogenesis].
    Furukawa Y; Nishi K; Mizuno Y; Narabayashi H
    No To Shinkei; 1995 Mar; 47(3):261-8. PubMed ID: 7669428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.
    Kishore A; Nygaard TG; de la Fuente-Fernandez R; Naini AB; Schulzer M; Mak E; Ruth TJ; Calne DB; Snow BJ; Stoessl AJ
    Neurology; 1998 Apr; 50(4):1028-32. PubMed ID: 9566390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystonia with marked diurnal variation associated with biopterin deficiency.
    Fink JK; Barton N; Cohen W; Lovenberg W; Burns RS; Hallett M
    Neurology; 1988 May; 38(5):707-11. PubMed ID: 2452381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopa-responsive dystonia: [18F]dopa positron emission tomography.
    Sawle GV; Leenders KL; Brooks DJ; Harwood G; Lees AJ; Frackowiak RS; Marsden CD
    Ann Neurol; 1991 Jul; 30(1):24-30. PubMed ID: 1681782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia.
    Furukawa Y; Shimadzu M; Rajput AH; Shimizu Y; Tagawa T; Mori H; Yokochi M; Narabayashi H; Hornykiewicz O; Mizuno Y; Kish SJ
    Ann Neurol; 1996 May; 39(5):609-17. PubMed ID: 8619546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations.
    Furukawa Y; Kish SJ; Bebin EM; Jacobson RD; Fryburg JS; Wilson WG; Shimadzu M; Hyland K; Trugman JM
    Ann Neurol; 1998 Jul; 44(1):10-6. PubMed ID: 9667588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
    Furukawa Y; Mizuno Y; Narabayashi H
    Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147
    [No Abstract]   [Full Text] [Related]  

  • 14. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia.
    Furukawa Y; Kapatos G; Haycock JW; Worsley J; Wong H; Kish SJ; Nygaard TG
    Ann Neurol; 2002 May; 51(5):637-41. PubMed ID: 12112113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterin abnormalities in dystonia: a metabolic marker with therapeutic implications.
    LeWitt PA; Miller LP; Levine RA; Lovenberg W; Newman RP; Papavasiliou A; Rayes A; Eldridge R; Burns RS
    Adv Neurol; 1988; 50():193-201. PubMed ID: 2456675
    [No Abstract]   [Full Text] [Related]  

  • 16. [Segawa disease (hereditary progressive dystonia with marked diurnal fluctuation-HPD) and abnormalities in pteridin metabolism].
    Segawa M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1322-3. PubMed ID: 9128393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia.
    Calne DB; de la Fuente-Fernández R; Kishore A
    J Neural Transm Suppl; 1997; 50():47-52. PubMed ID: 9120424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical heterogeneity of dopa-responsive dystonia: PET observations.
    Takahashi H; Snow BJ; Nygaard TG; Calne DB
    Adv Neurol; 1993; 60():586-90. PubMed ID: 8420195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segawa disease with a novel heterozygous mutation in exon 5 of the GCH-1 gene (E183K).
    Ikeda T; Kanmura K; Kodama Y; Sawada K; Nunoi H; Hasegawa K
    Brain Dev; 2009 Feb; 31(2):173-5. PubMed ID: 18621497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation.
    Fink JK; Ravin P; Argoff CE; Levine RA; Brady RO; Hallett M; Barton NW
    Neurology; 1989 Oct; 39(10):1393-5. PubMed ID: 2477772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.